Tissue Repair Ltd (ASX:TRP)
0.0820
0.00 (0.00%)
Sep 18, 2026, 3:28 PM AEST
Tissue Repair Revenue
In the fiscal year ending June 30, 2026, Tissue Repair had annual revenue of 2.99M AUD with 13.58% growth. Tissue Repair had revenue of 1.59M in the half year ending June 30, 2026, a decrease of -8.26%.
Revenue
2.99M
Revenue Growth
+13.58%
P/S Ratio
1.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 2.99M | 357.51K | 13.58% |
| Jun 30, 2025 | 2.63M | 842.43K | 47.04% |
| Jun 30, 2024 | 1.79M | 819.21K | 84.31% |
| Jun 30, 2023 | 971.66K | 799.73K | 465.18% |
| Jun 30, 2022 | 171.92K | 19.29K | 12.63% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Acrux | 6.58M |
| Vectus Biosystems | 2.77M |
| Cynata Therapeutics | 1.71M |
| Bio-Gene Technology | 1.08M |
| Nexalis Therapeutics | 1.07M |
| Biotron | 525.87K |
| ReNerve | 510.36K |
| AdAlta | 404.25K |